Overview VA106483 Dose Response Study in Elderly Males Status: Completed Trial end date: 2009-09-01 Target enrollment: Participant gender: Summary The main purpose of the study is to evaluate the way VA106483 enters and leaves the blood and tissues over time and how the drug acts on and in the body at various dose levels compared to placebo in the same volunteer. Phase: Phase 1 Details Lead Sponsor: Vantia Ltd